Latham Named Mergers & Acquisitions Law Firm of the Year
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”
Nicole Liffrig Molife is counsel in the Washington, D.C. office of Latham & Watkins and a member of the Healthcare and Life Sciences Practice. Nicole provides healthcare regulatory advice on transactions to a diverse set of early stage and established healthcare and life sciences clients throughout the industry, including:
Nicole's practice focuses on healthcare transactions and regulatory counseling matters. She advises clients on healthcare regulatory, compliance, and business considerations that clients in the healthcare and life sciences industry face in transactions and contractual arrangements. These matters have included mergers, acquisitions, financings, securities offerings, joint ventures, contractual affiliations and other business agreements, and consulting and service agreements involving a wide variety of healthcare and life sciences companies. She handles a range of healthcare regulatory matters including fraud and abuse counseling, voluntary self-disclosures, and investigations involving the Stark Law, the Federal Anti-Kickback Statute, the False Claims Act, Medicare and Medicaid regulations, and policies.
Nicole writes and speaks frequently on a variety of healthcare and life sciences topics, including healthcare compliance risks and regulatory structural considerations arising in healthcare transactions, fraud and abuse risks in Health IT agreements, compliance with the Stark Law, contract negotiation and due diligence strategies, and Medicare coverage and reimbursement matters. Recent thought leadership includes:
Recent examples of Nicole's experience serving as regulatory counsel includes representation of:
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”